Радионуклидная диагностика для практических врачей - Лишманова Ю.Б.
ISBN 5-93629-166-9
Скачать (прямая ссылка):
144. Moretti J.L., Defer G., Cinotti L. «Luxury-perfusion» with Tc-99m-HMPAO and І-123-ІМР SPECT imaging during the subacute phase of stroke // Eur. Nucl. Med. - 1990. - Vol. 16. - P. 17-22.
145. Mountz J., McGillicuddy J.E., Wilson M.W. et al. Sequential Tc-99m-RBC CBV and 99m-Tc-HM-PAO CBF SPECT: Correlation with neurologic deficits in patients with cerebral ischemia // J. Nucl. Med. - 1990. - Vol. 31(5 Suppl.). - P. 790-796.
146. Mountz J.M. A method of analysis of SPECT blood flow image data for comparison with computed tomography // Clin. Nucl. Med. - 1989. -Vol. 14(3). - P. 192-196.
147. Mountz J.M., Deutsch G., Herherington H.R et al. Applications of rCBF brain SPECT and NMR imaging in the evaluation of stroke: implications in rehabilition prognosis // SPECT in neurology and psychiatry / Ed. by De Deyn P.P., Dierckx R.A., Alavi A., Pickut B.A. - London: Jonn Libbey&Company Ltd, 1997. - P. 335-345.
148. Muller-Gartner H.W., Fisher R.S., Lesser R.P. et al. Decreased binding of I-123 iodo dexetimide to muscarinic cholinergic receptors in hippocampus in temporal lobe epilepsy//JNM. - 1991. - Vol. 33. - P. 928.
149. Munaka M., Iida H. New quantification of regional cerebral blood flow measurements by 123I-IMP SPECT with the rotating gamma camera -theory and validation of the look-up table method // Kaku-lgaku. - 1992. - Vol. 29 (3). - P. 385-389.
150. Murase K., Tanada S., Fujita H. Kinetic behavion of Tc-99m-HMPAO in the human brain and quantification of CBF using dynamic SPECT // J. Nucl. Med. - 1992. - Vol. 33 (3). - P. 135-143.
151. Nariai T, Suzuki R., Hirakawa K. et al. Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography//AJNR. - 1995. - Vol. 16. - P. 563-570.
152. Neary D., Snowden J.S., Northen В. etal. Dementia of the frontal lobe type// J. Neurosurg. Psychiatry. - 1998. - Vol. 51. - P. 353-361.
153. Neirinckx R.D. Evaluation of regional cerebral blood flow with 99mTc-d,l HM-PAO and SPECT// Neurosurg. Rev. - 1987. - Vol. 10 (3):181-184.
154. Newberg A.B., Alavi A. Neuroimaging in patients with head trauma // SPECT in neurology and psychiatry / Ed. by De Deyn P.P., Dierckx R.A., Alavi A., Pickut B.A. - London: Jonn Libbey&Company Ltd, 1997. - P. 409-414.
155. Nickel 0., Ulrich P., Naegele-Woehrle B. RCBF-Quantifictionwith 99m-Tc-HMPAO SPECT and 195m-Au: Theory and First Results. Nuclear Medicine: New Trends and Possibilities in Nucl. Med // Eur. Nucl. Med. Congr.; 24-28 Aug. 1987. - Budapest, 1988. - P. 289-293.
156. Nordstrom A.-L., Farde L, Wiesel F.-A. et al. Central D2 dopamine receptor occupancy in relation to antipsychotic drug effects: a double blind PET study of schizophrenic patients // Biol. Psychiatry. - 1993. - Vol. 33. - P. 227-35.
2.12. Радионуклидная диагностика в неврологии и психиатрии
385
157. Obrist W.D., Thompson Н.К., King С.H., Wang H.S. Determination of rCBF by inhalation of 133-Xenon // Circ. Res. - 1967. - Vol. 20 (1). -P. 124-130.
158. O'Connell R.A., Van Heertum R.L., Billick S.B. et al. Single photon emission computed tomography (SPECT) with IMP in the differential diagnosis of psychiatric disorders //J. Neuropsychiatry. - 1989. - Vol. 1. - P. 145-153.
159. Oriuchi N., Tamura M., Shibazaki T. et al. Clinical evaluation of thallium-201 SPECT in supratentorial glio-mas: Relationship to histologic grade, prognosis and prolif-erative activities // J. Nucl. Med. - 1993. - Vol. 34. - P. 2085-2089.
160. Pantano P., Baron J.C., Samson Y. Crossed cerebellar diaschisis. Further studies // Brain. - 1986. - Vol. 109. - P. 677-694.
161. Paulman R.G., Devous M.D., Gregory R.R. et al. Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function // Biol. Psychiatry. - 1990. - Vol. 27. - P. 377-399.
162. Perani D., DiPiero V, Vallar G. et al. Technetium-99m HM-PAO SPECT study of regional cerebral perfusion in early Alzheimer's disease//J. Nucl. Med.- 1988.-Vol. 29.-P. 1507-1514.
163. Perkins A.C. Tumor imaging //M.N. Maisey, K.E. Britton, B.D.Collier (eds). Clinical nuclear medicine. - London: Chapman & Hall Medical, 1998.
- P. 272-284.
164. Perry R.H., Irving D., Blessed, G. etal. Senile dementia of the Lewy body type//J. Neurol. Sei. - 1990. - Vol. 95. - P. 119-139.
165. Pilowsky L.S. Tracers // M.N. Maisey, K.E. Britton, B.D. Collier (eds). Clinical nuclear medicine. - London: Chapman & Hall Medical, 1998. -P. 277-286.
166. PizzolatoG., Dam M., Borsato N. et al. Tc-99m-HM-PAO SPECT in Parkinson's disease// J. Cereb. Blood Flow Metab. - 1988. - Vol. 8. - P. 101-108.
167. Podreka 1., Hoell K., Dai-Bianco P. Klinische und technische Aspekte der SPECT-Hirnszintigraphie mit 123-l-N-isopropyl-Amphetamin // Nucl. Compact. - 1984. - Vol. 15. - P. 305-314.
168. Podreka I., Suess E., Goldenberg G. etal. Initial experience with technetium-99m HM-PAO brain SPECT//J. Nucl. Med. - 1987. - Vol. 26(11).
